Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | VEGF | 835.0 | 55 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | VEGF | 906.0 | 63 | |
RA2159 | EO1428 | 1.0 | uM | 1 | VEGF | 506.0 | 62 | ||||
N2586 | TNF-a | 100 | ng/mL | 1 | VEGF | 1069.0 | 74 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | VEGF | 1337.0 | 49 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | VEGF | 1048.5 | 68 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | VEGF | 1467.0 | 37 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | VEGF | 958.0 | 33 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | VEGF | 707.5 | 56 | |
N2586 | EO1428 | 1.0 | uM | 1 | VEGF | 1240.0 | 37 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 1 | VEGF | 962.0 | 39 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | VEGF | 1187.0 | 71 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | VEGF | 642.0 | 67 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | VEGF | 1130.0 | 60 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | VEGF | 1069.5 | 56 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | VEGF | 619.5 | 72 | |
RA2159 | PI103 | 0.1 | uM | 1 | VEGF | 695.0 | 75 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 1 | VEGF | 1595.0 | 70 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | VEGF | 1535.0 | 51 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | VEGF | 1255.0 | 65 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | VEGF | 1540.0 | 46 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | VEGF | 1744.5 | 46 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | VEGF | 1167.5 | 50 | |
N2586 | PI103 | 0.1 | uM | 1 | VEGF | 756.0 | 57 | ||||
RA2159 | IL-6 | 100 | ug/mL | 1 | VEGF | 1042.5 | 82 |